BiotechTube

CT-P10 + Rituxan

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Follicular Lymphoma

Conditions

Follicular Lymphoma

Trial Timeline

Nov 9, 2015 → Sep 4, 2019

NCT ID
NCT02260804

About CT-P10 + Rituxan

CT-P10 + Rituxan is a phase 3 stage product being developed by Celltrion for Follicular Lymphoma. The current trial status is completed. This product is registered under clinical trial identifier NCT02260804. Target conditions include Follicular Lymphoma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02260804Phase 3Completed

Competing Products

20 competing products in Follicular Lymphoma

See all competitors
ProductCompanyStageHype Score
EnzastaurinEli LillyPhase 2
52
Rituxan + CT-P10 + Cyclophosphamide + Vincristine + PrednisoneCelltrionPhase 3
77
TazemetostatEisaiPre-clinical
23
Zandelisib + Rituximab + Bendamustine + CHOPKyowa KirinPhase 3
77
Pirtobrutinib + MosunetuzumabEli LillyPhase 2
52
fludarabine + rituximab + VELCADEJohnson & JohnsonPhase 2
52
SHR2554Jiangsu Hengrui MedicinePhase 2
52
Epcoritamab + RituximabAbbViePhase 2
52
Epcoritamab + Rituximab + LenalidomideAbbViePhase 3
77
Ibrutinib + VenetoclaxAbbViePhase 1/2
41
Epcoritamab + Prednisone + Rituximab + Lenalidomide + Doxorubicin + Vincristine + Cyclophosphamide + Obinutuzumab + BendamustineAbbViePhase 3
77
Venetoclax + Bendamustine + RituximabAbbViePhase 2
52
Acalabrutinib + ObinutuzumabAstraZenecaPhase 2
52
Surovatamig + R-CHOP + R-CVP + BRAstraZenecaPhase 3
77
Gonal-F (Follitropin alfa)MerckPre-clinical
23
Eltrombopag and VorinostatMerckPhase 2
52
Recombinant-follicle stimulating hormone (r-FSH)MerckPre-clinical
23
Acalabrutinib + PembrolizumabMerckPhase 1/2
41
Rituximab + Autologous dendritic cells + GM-CSF + PembrolizumabMerckPhase 2
52
G100 + Pembrolizumab + RituximabMerckPhase 1/2
41

Other Products from Celltrion

Azathioprine + PlaceboApproved
85
Infliximab CT-P13 + Immunosuppressors (Thiopurines or Methotrexate)Approved
85
Infliximab + Infliximab + InfliximabApproved
85
Pioglitazone + Alogliptin + Alogliptin + Metformin + DapagliflozinApproved
85
Pioglitazone 15 MG [Actos] + Empagliflozin 10 MG [Jardiance] + Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]Approved
85